Top pharmaceutical companies by capex growth in 2018/2019

Kiniksa Pharmaceuticals had the highest capex growth among pharma and biotech companies worldwide during the 2018/2019 period, with a growth rate of over 7,500 percent. Capital expenditures are defined as funds used by a company to acquire or upgrade physical assets, such as property, industrial buildings, or equipment.

U.S. pharmaceutical and biotech industry

Several of the pharmaceutical companies with high capex growth rates are based in the United States, for example, TG Therapeutics, Karyopharm, and Odonate Therapeutics. In 2018, the country accounted for roughly 40 percent of the global pharmaceutical market. China, which has a much larger population than the United States, had an 11 percent market share. In the same year, the United States spent roughly 480 billion U.S. dollars on medicine. This was more than double the amount spent 16 years earlier.

In 2019, the largest American pharmaceutical company based on revenue was Cardinal Health Inc (according to the FT Global 500). The multinational health care services company is headquartered in Dublin, Ohio, and generated over 140 billion U.S. dollars’ worth of revenue during 2019. However, Cardinal Health is not a ‘classical’ pharmaceutical manufacturing company, but more involved in pharma distribution.

World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2018/2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2019

Region

Worldwide

Survey time period

2018 and 2019

Supplementary notes

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.